β2-adrenergic receptors inhibit the expression of collagen type II in growth plate chondrocytes by stimulating the AP-1 factor Jun-B

American Journal of Physiology - Endocrinology and Metabolism

Volumn 300, Issue 4, 2011, Pages 633-639

  Mitchell, Jane ^a   Lai, Lick Pui ^a   Peralta, Faye ^a   Xu, Yenan ^a   Sugamori, Kim ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Activator protein 1 factor; Growth plate; Sox 6

Indexed keywords

ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR; COLLAGEN TYPE 2; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOPRENALINE; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROPRANOLOL; PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND; TRANSCRIPTION FACTOR SOX6;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; GROWTH PLATE; INHIBITION KINETICS; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ADRENERGIC BETA-AGONISTS; ANIMALS; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; DOWN-REGULATION; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH PLATE; HUMANS; ISOPROTERENOL; MICE; PREGNANCY; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, ADRENERGIC, BETA-2; RNA, SMALL INTERFERING; SOXD TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR AP-1;

EID: 79955151416     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00515.2010     Document Type: Article

References (32)

1. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-157, 1991.
2. Chung U, Lanske B, Lee K, Li E, Kronenberg H. The parathyroid hormone/parathyroid hormone related-peptide receptor coordinates end ochondral bone development by directly controlling chondrocyte differentiation. Proc Natl Acad Sci USA 95: 13030-13035, 1998.
3. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100: 197-207, 2000.
4. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434: 514-520, 2005.
5. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The mole cularclock mediates leptin-regulated bone formation. Cell 122: 803-815, 2005.
6. Guo J, Chung UI, Kondo H, Brinkhurst FR, Kronenberg HM. The PTH/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C. Dev Cell 3: 183-194, 2002.
7. Hess J, Hertenstein B, Teurich S, Schmidt D, Schorpp-Kistner M, Angel P. Defective endochondral ossification in mice with strongly compromised expression of Jun B. J Cell Sci 116: 4587-4596, 2003.
8. Hwang SG, Yu SS, Lee SW, Chun JS. Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway. FEBS Lett 579: 4837-4842, 2005.
9. Hwang SG, Yu SS, Poo H, Chun JS. c-Jun/activator protein-1 mediates interleukin-1_-induced dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes. J Biol Chem 280: 29780-29787, 2005.
10. Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 12: 186-192, 2000.
11. Kitaura T, Tsunekawa N, Kraemer WJ. Inhibited longitudinal growthof bones in young male rats by clenbuterol. Med Sci Sports Exerc 34: 267-273, 2002.
12. Krejci P, Bryja V, Pachernik J, Hampl A, Pogue R, Mekikian P, Wilcox WR. FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells. Exp Cell Res 297: 152-164, 2004.
13. Kronenberg HM. Developmental regulation of the growth plate. Nature 423: 332-336, 2003.
14. Lai LP, Dasilva KA, Mitchell J. Regulation of Indian hedgehog mRNAlevels in chondrocytic cells by ERK1/2 and p38 mitogen-activated proteinkinases. J Cell Physiol 203: 177-185, 2005.
15. Lai LP, Mitchell J. β2-adrenergic receptors expressed on murine chondrocytes stimulate cellular growth and inhibit the expression of Indian hedgehog and collagen type X. J Cell Biochem 104: 545-553, 2008.
16. Lefebvre Huang W, Harley VR, Goodfellow PN, de Crombrugghe B. Sox9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17: 2336-2346, 1997.
17. Maor G, Rochwerger M, Segev Y, Phillip M. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res 17: 1034-1043, 2002.
18. Maudsley S, Pierce KL, Zamah AM, Miller WE, Ahn S, Daaka Y, Lefkowitz RJ, Luttrell LM. The beta(2)-adrenergic receptor mediatesextracellular signal-regulated kinase activation via assembly of a multireceptor complex with the epidermal growth factor receptor. J Biol Chem 275: 9572-9580, 2000.
19. Morgan NG, Blackmore PF, Exton JH. Age-related changes in the control of hepatic cyclic AMP levels by alpha 1- and beta 2-adrenergic receptors in male rats. J Biol Chem 258: 5103-5109, 1983.
20. Raucci A, Laplantine E, Mansukhani A, Basilico C. Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes. J Biol Chem 279: 1747-1756, 2004.
21. Sakamoto A, Chen M, Kabayashi T, Kronenberg HM, Weinstein LS. Chondrocyte-specific knockout of the G protein G(s)alpha leads to epiphysial and growth plate abnormalities and ectopic chondrocyte formation. J Bone Miner Res 20: 663-671, 2005.
22. Schaffner W, Weissmann C. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem 56: 502-514, 1973.
23. Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, Reiter E, Premont RT, Lichtarge O, Lefkowitz RJ. beta-arrestindependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 281: 1261-1273, 2006.
24. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 92:73-78, 2000.
25. Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylatesMAP kinase in vivo. Cell 75: 487-493, 1993.
26. Takarada T, Hojo H, Iemata M, Sahara K, Kodama A, Nakamura N, Hinoi E, Yoneda Y. Interference by adrenaline with chondrogenic differentiationthrough supression of gene transactivation mediated by Sox9 family members. Bone 45: 568-578, 2009.
27. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305-317, 2002.
28. Thomas DP, Sunters A, Gentry A, Grigoriadis AE. Inhibition of chondrocyte differentiation in vitro by constitutive and inducible over expression of the c-fos proto-oncogene. J Cell Sci 113: 439-450, 2000.
29. Wagner EF. Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis 61, Suppl 2: ii40-ii42, 2002.
30. Wang Y, Spatz MK, Kannan K, Hayk H, Avivi A, Gorivodsky M, Pines M, Yayon A, Lonai P, Givol D. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc Natl Acad Sci USA 96: 4455-4460, 1999.
31. Wang ZQ, Grigoriadis AE, Wagner EF. Stable murine chondrogeniccell lines derived from c-fos-induced cartilage tumors. J Bone Miner Res 8: 839-847, 1993.
32. Zhou G, Lefebvre V, Zhang Z, Eberspaecher H, de Cromrugghe B. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem 273: 14989-14997, 1998.